Why the study?
Does the end-systolic pressure-volume relation (ESPVR) provide additive prognostic value in patients with diabetes mellitus who have negative dobutamine stress echocardiography by wall motion criteria?
Does the end-systolic pressure-volume relation (ESPVR) provide additive prognostic value in patients with diabetes mellitus who have negative dobutamine stress echocardiography by wall motion criteria?
In diabetic patients with negative dobutamine stress echocardiography by wall motion criteria, a blunted end-systolic pressure-volume relation response provides additive prognostic value for predicting adverse cardiovascular events.
No takes yet. Share an insight, caveat, or question.
May refine risk stratification among diabetics with negative DSE; hypothesis-generating and requires prospective validation before practice change.
Cortigiani et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: